White House to launch effort to develop next-gen Covid vaccines; Pfizer loses another round in court

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     White House to launch effort to develop next generation of Covid vaccines By Matthew Herper and Lev Facher NIAID/NIH The Biden administration is kicking off the effort with a summit featuring federal officials, top scientists, and pharmaceutical executives. Read More STAT+: Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs By Ed Silverman APStock A federal appeals court panel upheld a ruling which found that planned Pfizer copay assistance programs would violate kickback laws. Read More Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis By Andrew Joseph Michael Thomas for STAT A cluster of overdose deaths in St. Louis captures how the drug epidemic has taken on new dangers and is claiming different sets of victims. Read More Sponsor content by PhRMA 340B is helping big hospitals & chain pharmacies The 340B program was designed to help patients. Instead, it has become less about patients and more about boosting the bottom lines of big hospitals and chain pharmacies. Large hospitals buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insurance companies higher prices, pocketing the difference with little to no evidence they use that money to help those who actually need it. Does that seem fair to patients? Learn more. STAT+: McDonald's is criticized for leaving antibiotic reduction targets off its menu By Ed Silverman Gene J. Puskar/AP "Without a target, you’re not reducing... they should have left the language in the policy," said Steve Roach of Food Animal Concerns Trust. Read More Opinion: Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements By Reuben Guttman and Liza Vertinsky Seth Wenig/AP The massive opioid-related settlements won by state Attorneys General should be industry-changing events. Secrecy will thwart that. Read More Monday, July 25, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser